Hospitalization for infection in patients treated for giant cell arteritis: A single-centre retrospective study

被引:1
|
作者
Lavrad-Meyer, P. [1 ]
De Pinho, Q. Gomes [1 ]
Daumas, A. [2 ]
Benyamine, A. [1 ]
Ebbo, M. [3 ]
Schleinitz, N. [3 ]
Harle, J. R. [3 ]
Jarrot, P. A. [4 ]
Kaplanski, G.
Berbis, J. [5 ]
Granel, B. [1 ]
机构
[1] Aix Marseille Univ AMU, Hop Nord, Assistance Publ Hop Marseille APHM, Serv Med Interne, Marseille, France
[2] Aix Marseille Univ AMU, Hop Timone, AP HM, Serv Med Interne Geriatr & Therapeut, Marseille, France
[3] Aix Marseille Univ AMU, Hop Timone, AP HM, Serv Medecine Interne, Marseille, France
[4] Aix Marseille Univ AMU, Hop Concept, AP HM, Serv Med Interne & Immunol Clin, Marseille, France
[5] Aix Marseille Univ AMU, Fac Med Timone, Ctr Etud & Rech Serv Sante & Qual Vie, Lab Sante Publ,EA 3279, Marseille, France
来源
REVUE DE MEDECINE INTERNE | 2023年 / 44卷 / 05期
关键词
MULTICENTER; MORTALITY; COHORT;
D O I
10.1016/j.revmed.2023.02.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - Infections are associated with morbimortality of patients with giant cell arteritis (GCA). The aim of this work was twofold: the identification of factors predisposing to the risk of infection and the description of patients hospitalized with an infection occurring during the treatment period of CAG.Methods. - A monocentric retrospective study was conducted in GCA patients, comparing patients hospi-talized for infection with patients without infection. The analysis included 21/144 (14.6%) patients with 26 infections (cases) and 42 control matched on sex, age, and diagnosis of GCA. Results. - Both groups were similar except for a higher frequency of seritis in cases (15% vs. 0%, p = 0.03). Relapses of GCA were less common in cases (23.8% vs 50.0%, p = 0.041). Hypogammaglobulinemia was present during infection. More than half of the infections (53.8%) occurred in the first year of follow-up with an average dose of 15 mg/day of corticosteroids. Infections were mainly pulmonary (46.2%) and cutaneous (26.9%). Conclusion. - Factors associated with infectious risk were identified. This preliminary monocentric work will continue with a national multicentre study.(C) 2023 Socie & PRIME;te & PRIME; Nationale Franc, aise de Me & PRIME;decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.</span>
引用
收藏
页码:212 / 217
页数:6
相关论文
共 50 条
  • [1] FLARE RATES IN GIANT CELL ARTERITIS: A SINGLE-CENTRE LONG-TERM RETROSPECTIVE STUDY
    Laskou, Faidra
    Koduri, Gouri
    Lever, Elliott
    Stapleton, Philip
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2017, 56 : 183 - 183
  • [2] Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study
    Yamaguchi, Eriho
    Kadoba, Keiichiro
    Watanabe, Ryu
    Iwasaki, Takeshi
    Kitagori, Koji
    Akizuki, Shuji
    Murakami, Kosaku
    Nakashima, Ran
    Hashimoto, Motomu
    Tanaka, Masao
    Morinobu, Akio
    Yoshifuji, Hajime
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 175 - 180
  • [3] Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study
    Berger, C. T.
    Greiff, V.
    John, S.
    Koenig, K. F.
    Bigler, M. B.
    Recher, M.
    Hess, C.
    Daikeler, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (02) : S122 - S125
  • [4] COULD THE RENIN-ANGIOTENSIN SYSTEM AFFECT THE PROGNOSIS OF GIANT CELL ARTERITIS? SINGLE-CENTRE RETROSPECTIVE OBSERVATIONAL STUDY
    Venkateswaran, R.
    Gour, K.
    Sorensen, L.
    Harden, C.
    Zhao, S. S.
    Morgan, A.
    Mackie, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1204 - 1205
  • [5] COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia
    Jelka Kramarič
    Rok Ješe
    Matija Tomšič
    Žiga Rotar
    Alojzija Hočevar
    Clinical Rheumatology, 2022, 41 : 2449 - 2456
  • [6] COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia
    Kramaric, Jelka
    Jese, Rok
    Tomsic, Matija
    Rotar, Ziga
    Hocevar, Alojzija
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2449 - 2456
  • [7] Colour Doppler ultrasound and the giant cell arteritis probability score for the diagnosis of giant cell arteritis: a Canadian single-centre experience
    Zarka, Farah
    Rheaume, Maxime
    Belhocine, Meriem
    Goulet, Michelle
    Febrer, Guillaume
    Mansour, Anne-Marie
    Troyanov, Yves
    Starnino, Tara
    Meunier, Rosalie-Selene
    Chagnon, Isabelle
    Routhier, Nathalie
    Benard, Valerie
    Ducharme-Benard, Stephanie
    Ross, Carolyn
    Makhzoum, Jean-Paul
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (03)
  • [8] Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study
    Tomelleri, Alessandro
    Campochiaro, Corrado
    Farina, Nicola
    Mariotti, Letizia
    Baldissera, Elena
    Grayson, Peter C.
    Matucci-Cerinic, Marco
    Dagna, Lorenzo
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 59
  • [9] ELIGIBILITY OF PATIENTS WITH GIANT CELL ARTERITIS FOR ENTRY INTO A PROSPECTIVE RANDOMISED CONTROLLED TRIAL: A SINGLE-CENTRE EXPERIENCE
    Schmidt, W. A.
    Hofheinz, K.
    Burger, S.
    Schaefer, V. S.
    Juche, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1496 - 1496
  • [10] Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study
    Hua-cong Cai
    Jia Chen
    Ting Liu
    Hao Cai
    Ming-hui Duan
    Jian Li
    Dao-bin Zhou
    Xin-xin Cao
    Orphanet Journal of Rare Diseases, 17